NO812879L - Faste legemiddeltilberedninger inneholdende nifedipin og fremgangsmaate til deres fremstilling - Google Patents

Faste legemiddeltilberedninger inneholdende nifedipin og fremgangsmaate til deres fremstilling

Info

Publication number
NO812879L
NO812879L NO812879A NO812879A NO812879L NO 812879 L NO812879 L NO 812879L NO 812879 A NO812879 A NO 812879A NO 812879 A NO812879 A NO 812879A NO 812879 L NO812879 L NO 812879L
Authority
NO
Norway
Prior art keywords
procedure
preparation
pharmaceutical preparations
solid pharmaceutical
preparations containing
Prior art date
Application number
NO812879A
Other languages
English (en)
Other versions
NO157368B (no
Inventor
Admed Hegasy
Klaus-Dieter Raemsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6111496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO812879(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO812879L publication Critical patent/NO812879L/no
Publication of NO157368B publication Critical patent/NO157368B/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO812879A 1980-09-09 1981-08-25 Fremgangsmaate til fremstilling av faste legemiddeltilberedninger inneholdende nifedipin. NO157368B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803033919 DE3033919A1 (de) 1980-09-09 1980-09-09 Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO812879L true NO812879L (no) 1982-03-10
NO157368B NO157368B (no) 1987-11-30

Family

ID=6111496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812879A NO157368B (no) 1980-09-09 1981-08-25 Fremgangsmaate til fremstilling av faste legemiddeltilberedninger inneholdende nifedipin.

Country Status (20)

Country Link
EP (1) EP0047899B2 (no)
JP (1) JPS5914446B2 (no)
AR (1) AR226377A1 (no)
AT (1) ATE5761T1 (no)
AU (1) AU558331B2 (no)
CA (1) CA1180277A (no)
DD (1) DD201974A5 (no)
DE (2) DE3033919A1 (no)
DK (1) DK154326C (no)
FI (1) FI72648B (no)
GR (1) GR78237B (no)
HU (1) HU184879B (no)
IE (1) IE51549B1 (no)
IL (1) IL63749A (no)
NO (1) NO157368B (no)
NZ (1) NZ198285A (no)
PH (1) PH24097A (no)
PL (1) PL232951A1 (no)
PT (1) PT73603B (no)
ZA (1) ZA816213B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4529733A (en) * 1983-04-06 1985-07-16 Merrell Dow Pharmaceuticals Inc. Antihypertensive 3-furoyl-1,4-dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
CH673947A5 (no) * 1986-09-23 1990-04-30 Sandoz Ag
JPS6464659A (en) * 1987-09-03 1989-03-10 Kenbi Kogaku Kenkyusho Kk Preparation of safe and effective powder formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
JPH0298550U (no) * 1989-01-25 1990-08-06
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
ES2168351T3 (es) * 1994-12-29 2002-06-16 Shire Deutschland Gmbh & Co Kg Preparaciones farmaceuticas que contienen nifedipina y procedimiento para su preparacion.
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
IL123505A (en) 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
ES2304980T3 (es) 1999-09-30 2008-11-01 Penwest Pharmaceuticals Co. Sistemas de matriz de liberacion sostenida para farmacos altamente solubles.
CN101862322A (zh) 2004-07-30 2010-10-20 托伦特药物有限公司 奈必洛尔及其药学可接受盐、制备方法以及奈必洛尔的药物组合物
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330727A (en) * 1960-04-19 1967-07-11 Glaxo Lab Ltd Griseofulvin with high specific surface area
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
CA1180277A (en) 1985-01-02
FI812758L (fi) 1982-03-10
PT73603B (en) 1982-11-10
GR78237B (no) 1984-09-26
IL63749A (en) 1984-06-29
DK154326C (da) 1995-03-13
NO157368B (no) 1987-11-30
EP0047899B1 (de) 1984-01-04
DE3033919A1 (de) 1982-04-22
EP0047899A1 (de) 1982-03-24
FI72648B (fi) 1987-03-31
DD201974A5 (de) 1983-08-24
NZ198285A (en) 1984-04-27
AU558331B2 (en) 1987-01-29
JPS5750913A (en) 1982-03-25
PL232951A1 (no) 1982-10-11
ATE5761T1 (de) 1984-01-15
DK154326B (da) 1988-11-07
IE812075L (en) 1982-03-09
HU184879B (en) 1984-10-29
JPS5914446B2 (ja) 1984-04-04
ZA816213B (en) 1982-09-29
DE3161838D1 (en) 1984-02-09
IL63749A0 (en) 1981-12-31
IE51549B1 (en) 1987-01-07
DK396381A (da) 1982-03-10
AU7506381A (en) 1982-03-18
PT73603A (en) 1981-09-01
AR226377A1 (es) 1982-06-30
EP0047899B2 (de) 1996-02-28
PH24097A (en) 1990-03-05

Similar Documents

Publication Publication Date Title
NO812879L (no) Faste legemiddeltilberedninger inneholdende nifedipin og fremgangsmaate til deres fremstilling
DK165949C (da) 1,4-dihydropyridinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne
DK539789A (da) Carbostyrilderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant carbostyrilderivat
DK110886D0 (da) Hidtil ukendte sulfonylaminoforbindelser, fremgangsmaader til deres fremstilling, og farmaceutiske praeparater, der indeholder forbindelserne
DK211084D0 (da) Hurtigtoploesende laegemiddelpraeparater og fremgangsmaade til fremstilling heraf
DK307482A (da) Carbostyrilforbindelser praeparater indeholdende disse og fremgangsmaade til deres fremstilling
DK127588A (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK218985A (da) Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af dem
DK306982A (da) Aerosol-praeparater paa vmadbasis og fremgangsmaade til deres fremstilling
DK183986A (da) Cyklopentylaetere, fremgangsmaade til fremstilling deraf og laegemiddelpraeparat indeholdende saadanne forbindelser
DK228285D0 (da) Dihydropyridinpraeparater og fremgangsmaader til deres fremstilling
DK612788D0 (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK488385A (da) N6-bicycloadenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser
DK340388A (da) Aminocyklopentylaetere, fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
DK415388A (da) Farmaceutiske praeparater indeholdende pyrimidinderivater og fremgangsmaade til fremstilling deraf
DK634788D0 (da) 22-deklorteicoplaniner, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
DK262186A (da) Quinolinderivater, farmaceutisk praeparat indeholdende saadanne forbindelser og fremgangsmaade til fremstilling deraf
DK228185A (da) Nifedipinpraeparater og fremgangsmaader til deres fremstilling
DK142682A (da) 1-benzoyl-3-(6-oxopyridazinyl)-urinstoffer,fremgangsmaade til deres fremstilling og insekticide praeparater indeholdende dem
DK228085A (da) Nifedipinkombinationspraeparater og fremgangsmaader til deres fremstilling
DK458078A (da) 4-phenylthieno-(2,3-c) piperidiner fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
DK528481A (da) Bis-hydroxybenzylderivater fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende dem
DK457386A (da) 4-substituerede catechol-derivater, fremgangsmaade til fremstillingderaf og farmaceutiske praeparater indeholdende saadanne derivater
DK180588A (da) Anti-tumor-virksomme praeparater og fremgangsmaade til deres fremstilling